Cite
An HDAC9-associated immune-related signature predicts bladder cancer prognosis.
MLA
Yang Fu, et al. “An HDAC9-Associated Immune-Related Signature Predicts Bladder Cancer Prognosis.” PLoS ONE, vol. 17, no. 3, Jan. 2022, p. e0264527. EBSCOhost, https://doi.org/10.1371/journal.pone.0264527.
APA
Yang Fu, Shanshan Sun, Jianbin Bi, Chuize Kong, & Du Shi. (2022). An HDAC9-associated immune-related signature predicts bladder cancer prognosis. PLoS ONE, 17(3), e0264527. https://doi.org/10.1371/journal.pone.0264527
Chicago
Yang Fu, Shanshan Sun, Jianbin Bi, Chuize Kong, and Du Shi. 2022. “An HDAC9-Associated Immune-Related Signature Predicts Bladder Cancer Prognosis.” PLoS ONE 17 (3): e0264527. doi:10.1371/journal.pone.0264527.